TipRanks
AN2 Therapeutics, Inc. (ANTX)
NASDAQ:ANTX
US Market
ANTX
AN2 Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see ANTX full AI Analyst Report?

AN2 Therapeutics, Inc. (ANTX) Stock News & Sentiment

108 Followers
Analyst Sees Material Upside for AN2 Therapeutics as Epetraborole Targets Underserved Polycythemia Vera Market
Premium
Ratings
Analyst Sees Material Upside for AN2 Therapeutics as Epetraborole Targets Underserved Polycythemia Vera Market
3M ago
ANTX
AN2 Therapeutics Holds 2026 Annual Stockholder Meeting
Premium
Company Announcements
AN2 Therapeutics Holds 2026 Annual Stockholder Meeting
4M ago
8K
ANTX
AN2 Therapeutics Advances Chagas Candidate After Positive Trials
Premium
Company Announcements
AN2 Therapeutics Advances Chagas Candidate After Positive Trials
4M ago
8K
ANTX
AN2 Therapeutics, Inc. (ANTX) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
AN2 Therapeutics, Inc. (ANTX) Q1 Earnings Cheat Sheet
5M ago
ANTX
AN2 Therapeutics Completes First-in-Human Trial, Setting Up the Next Catalyst for ANTX
Premium
Company Announcements
AN2 Therapeutics Completes First-in-Human Trial, Setting Up the Next Catalyst for ANTX
6M ago
ANTX
AN2 Therapeutics Launches New $80 Million ATM Program
Premium
Company Announcements
AN2 Therapeutics Launches New $80 Million ATM Program
6M ago
8K
ANTX
AN2 Therapeutics Reprices Stock Options to Enhance Retention
Premium
Company Announcements
AN2 Therapeutics Reprices Stock Options to Enhance Retention
7M ago
8K
ANTX
More ANTX News >

ANTX News on the Web

Insider Confidence Surges as AN2 Therapeutics Director Adds to Her Stake
TipRanks News
Neutral
AN2 Therapeutics presents clinical data supporting development of Epetraborole
TipRanks News
Bullish
Analyst Sees Material Upside for AN2 Therapeutics as Epetraborole Targets Underserved Polycythemia Vera Market
TipRanks News
Bullish
AN2 Therapeutics initiated with a Buy at Guggenheim
TipRanks News
Bullish
AN2 Therapeutics Advances Chagas Candidate After Positive Trials
TipRanks News
Bullish
AN2 Therapeutics reports data from two studies of AN2-502998 in Chagas disease
TipRanks News
Bullish
AN2 Therapeutics upgraded to Outperform from Market Perform at Leerink
TipRanks News
Neutral
AN2 Therapeutics reports Q1 EPS (29c), one estimate (23c)
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.25 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ANTX’s Media Buzz Sentiment?
Currently, no data Available
What is ANTX’s weekly average amount of articles?
In an average week, 0.25 articles about ANTX are published.
    What is ANTX’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    IQVIQVIA Holdings
    GILDGilead Sciences
    ABBVAbbVie
    VRTXVertex Pharmaceuticals
    NVSNovartis
    Showing the stocks with the most bullish news sentiment over the past week